Cargando…

Once BCG Unresponsive, Always BCG Unresponsive: An Open Letter to the FDA to Enhance Recruitment into Clinical Trials in Bladder Cancer

Detalles Bibliográficos
Autores principales: Kamat, Ashish M., Lerner, Seth, Black, Peter, Bellmunt, Joaquim, Dinney, Colin, Hahn, Noah M., O’Donnell, Michael, Quale, Diane Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545902/
https://www.ncbi.nlm.nih.gov/pubmed/28824940
http://dx.doi.org/10.3233/BLC-170118
_version_ 1783255502503804928
author Kamat, Ashish M.
Lerner, Seth
Black, Peter
Bellmunt, Joaquim
Dinney, Colin
Hahn, Noah M.
O’Donnell, Michael
Quale, Diane Z.
author_facet Kamat, Ashish M.
Lerner, Seth
Black, Peter
Bellmunt, Joaquim
Dinney, Colin
Hahn, Noah M.
O’Donnell, Michael
Quale, Diane Z.
author_sort Kamat, Ashish M.
collection PubMed
description
format Online
Article
Text
id pubmed-5545902
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-55459022017-08-16 Once BCG Unresponsive, Always BCG Unresponsive: An Open Letter to the FDA to Enhance Recruitment into Clinical Trials in Bladder Cancer Kamat, Ashish M. Lerner, Seth Black, Peter Bellmunt, Joaquim Dinney, Colin Hahn, Noah M. O’Donnell, Michael Quale, Diane Z. Bladder Cancer Letter IOS Press 2017-07-27 /pmc/articles/PMC5545902/ /pubmed/28824940 http://dx.doi.org/10.3233/BLC-170118 Text en © 2017 – IOS Press and the authors. All rights reserved https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter
Kamat, Ashish M.
Lerner, Seth
Black, Peter
Bellmunt, Joaquim
Dinney, Colin
Hahn, Noah M.
O’Donnell, Michael
Quale, Diane Z.
Once BCG Unresponsive, Always BCG Unresponsive: An Open Letter to the FDA to Enhance Recruitment into Clinical Trials in Bladder Cancer
title Once BCG Unresponsive, Always BCG Unresponsive: An Open Letter to the FDA to Enhance Recruitment into Clinical Trials in Bladder Cancer
title_full Once BCG Unresponsive, Always BCG Unresponsive: An Open Letter to the FDA to Enhance Recruitment into Clinical Trials in Bladder Cancer
title_fullStr Once BCG Unresponsive, Always BCG Unresponsive: An Open Letter to the FDA to Enhance Recruitment into Clinical Trials in Bladder Cancer
title_full_unstemmed Once BCG Unresponsive, Always BCG Unresponsive: An Open Letter to the FDA to Enhance Recruitment into Clinical Trials in Bladder Cancer
title_short Once BCG Unresponsive, Always BCG Unresponsive: An Open Letter to the FDA to Enhance Recruitment into Clinical Trials in Bladder Cancer
title_sort once bcg unresponsive, always bcg unresponsive: an open letter to the fda to enhance recruitment into clinical trials in bladder cancer
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545902/
https://www.ncbi.nlm.nih.gov/pubmed/28824940
http://dx.doi.org/10.3233/BLC-170118
work_keys_str_mv AT kamatashishm oncebcgunresponsivealwaysbcgunresponsiveanopenlettertothefdatoenhancerecruitmentintoclinicaltrialsinbladdercancer
AT lernerseth oncebcgunresponsivealwaysbcgunresponsiveanopenlettertothefdatoenhancerecruitmentintoclinicaltrialsinbladdercancer
AT blackpeter oncebcgunresponsivealwaysbcgunresponsiveanopenlettertothefdatoenhancerecruitmentintoclinicaltrialsinbladdercancer
AT bellmuntjoaquim oncebcgunresponsivealwaysbcgunresponsiveanopenlettertothefdatoenhancerecruitmentintoclinicaltrialsinbladdercancer
AT dinneycolin oncebcgunresponsivealwaysbcgunresponsiveanopenlettertothefdatoenhancerecruitmentintoclinicaltrialsinbladdercancer
AT hahnnoahm oncebcgunresponsivealwaysbcgunresponsiveanopenlettertothefdatoenhancerecruitmentintoclinicaltrialsinbladdercancer
AT odonnellmichael oncebcgunresponsivealwaysbcgunresponsiveanopenlettertothefdatoenhancerecruitmentintoclinicaltrialsinbladdercancer
AT qualedianez oncebcgunresponsivealwaysbcgunresponsiveanopenlettertothefdatoenhancerecruitmentintoclinicaltrialsinbladdercancer